Page last updated: 2024-10-29

ketamine and Prader-Willi Syndrome

ketamine has been researched along with Prader-Willi Syndrome in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Prader-Willi Syndrome: An autosomal dominant disorder caused by deletion of the proximal long arm of the paternal chromosome 15 (15q11-q13) or by inheritance of both of the pair of chromosomes 15 from the mother (UNIPARENTAL DISOMY) which are imprinted (GENETIC IMPRINTING) and hence silenced. Clinical manifestations include MENTAL RETARDATION; MUSCULAR HYPOTONIA; HYPERPHAGIA; OBESITY; short stature; HYPOGONADISM; STRABISMUS; and HYPERSOMNOLENCE. (Menkes, Textbook of Child Neurology, 5th ed, p229)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sharma, AD1
Erb, T1
Schulman, SR1
Sreeram, G1
Slaughter, TF1

Other Studies

1 other study available for ketamine and Prader-Willi Syndrome

ArticleYear
Anaesthetic considerations for a child with combined Prader-Willi syndrome and mitochondrial myopathy.
    Paediatric anaesthesia, 2001, Volume: 11, Issue:4

    Topics: Analgesics; Androstanols; Anesthesia; Anesthetics, Dissociative; Anesthetics, Intravenous; Catheteri

2001